Mesenchymal Stem Cell Senescence and Biomaterial-Based Next-Generation Rejuvenation Strategy
Authors:
- 15 September 2025
- journal article
- review article
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
Abstract
The capacity for tissue regeneration declines with age, and cellular senescence is recognized as a critical driver of aging and impaired tissue regeneration potential. Advances in stem cell research have provided new insights into tissue regeneration and stem cell therapy in aging-related diseases. However, stem cell senescence significantly limits their therapeutic efficacy, highlighting the need for effective rejuvenation strategies. Current antisenescence approaches have shown promise, but they still face limitations. This review summarizes and discusses the characteristics and consequences of mesenchymal stem cells (MSCs) senescence and evaluates existing antisenescence strategies. Additionally, recent advancements in biomaterials have demonstrated considerable potential in modulating stem cell fate and enhancing tissue regeneration outcomes. In this context, we explore biomaterial-based approaches for rejuvenating senescent MSCs, offering novel perspectives for advancing tissue regeneration therapies targeting aging-related diseases.Keywords
Funding Information
- Australian Research Council Centre for Discovery Projects (DP220102876)
This publication has 91 references indexed in Scilit:
- Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axisCellular and Molecular Life Sciences, 2023
- Tissue Engineering of JAK Inhibitor‐Loaded Hierarchically Biomimetic Nanostructural Scaffold Targeting Cellular Senescence for Aged Bone Defect Repair and Bone RemoldingAdvanced Healthcare Materials, 2023
- Rapamycin and 3-Methyladenine Influence the Apoptosis, Senescence, and Adipogenesis of Human Adipose-Derived Stem Cells by Promoting and Inhibiting Autophagy: An In Vitro and In Vivo StudyAesthetic Plastic Surgery, 2021
- A bone matrix‐simulating scaffold to alleviate replicative senescence of mesenchymal stem cells during long‐term expansionJournal of Biomedical Materials Research Part A, 2020
- Doxorubicin‐induced senescence through NF‐κB affected by the age of mouse mesenchymal stem cellsJournal of Cellular Physiology, 2019
- Rescuing mesenchymal stem cell regenerative properties on hydrogel substrates post serial expansionBioengineering & Translational Medicine, 2018
- Polysaccharide biomaterials for drug delivery and regenerative engineeringPolymers for Advanced Technologies, 2014
- Cell Senescence Abrogates the Therapeutic Potential of Human Mesenchymal Stem Cells in the Lethal Endotoxemia ModelStem Cells, 2014
- Nanotopographical Effects on Mesenchymal Stem Cell Morphology and PhenotypeJournal of Cellular Biochemistry, 2013
- Adipose‐derived stem cell: a better stem cell than BMSCCell Biochemistry and Function, 2008